ICJEM

The Intercontinental Journal of Emergency Medicine aims to publish issues related to all fields of emergency medicine and all specialties involved in the management of emergencies in the hospital and prehospital environment of the highest scientific and clinical value at an international level and accepts articles on these topics.

EndNote Style
Index
Original Article
The significance of Systemic Immune-Inflammation Index, pan-immune-inflammation value, and Systemic Inflammation Response Index in the etiopathogenesis of acute pancreatitis
Aims: Acute pancreatitis (AP) is an inflammatory disease with a wide clinical spectrum ranging from mild self-limited inflammation to severe life-threatening complications. Early identification of disease severity is essential for appropriate clinical management. Recently, novel inflammatory indices derived from routine hematological parameters, including the Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), and Pan-Immune Inflammation Value (PIV), have been proposed as potential biomarkers reflecting systemic inflammatory status. This study aimed to evaluate the diagnostic and prognostic value of SII, SIRI, and PIV in patients with acute pancreatitis.
Methods: This retrospective observational study included 101 patients diagnosed with acute pancreatitis and 118 healthy controls. Demographic, clinical, and laboratory data were obtained from the hospital electronic medical record system. Laboratory parameters including white blood cell count, neutrophils, lymphocytes, platelets, C-reactive protein, serum amylase, and lipase were analyzed. SII, SIRI, and PIV values were calculated using standard formulas derived from peripheral blood cell counts. Group comparisons were performed using appropriate statistical tests, and receiver operating characteristic (ROC) curve analysis was conducted to determine the diagnostic performance of inflammatory indices. A p value <0.05 was considered statistically significant.
Results: Serum amylase, lipase, WBC count, neutrophil count, NLR, CRP, and inflammatory indices (SII, SIRI, and PIV) were significantly higher in patients with acute pancreatitis compared with the control group (p<0.05). ROC curve analysis demonstrated that these indices had strong diagnostic performance. Among the evaluated parameters, PIV showed the highest diagnostic accuracy with an area under the curve (AUC) of 0.895, followed by SIRI (AUC=0.890), SII (AUC=0.831), and NLR (AUC=0.823).
Conclusion: SII, SIRI, and PIV are practical and cost-effective biomarkers derived from routine laboratory parameters that may aid in the early diagnosis and prognostic evaluation of acute pancreatitis. These indices may help clinicians assess systemic inflammatory response and identify high-risk patients in the early stage of the disease. Further prospective multicenter studies are needed to confirm their clinical utility.


1. Peery AF, Crockett SD, Barritt AS, et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015;149(7):1731-1741.e3. doi:10.1053/j.gastro.2015.08.045
2. Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas. 2006;33(4):323-330. doi:10.1097/01.mpa.0000236733.31617.52
3. Thapa O, Basukala S, Shrestha M, et al. Acute recurrent pancreatitis in a child with pancreatic divisum- a case report. Ann Med Surg (Lond). 2022;82:104642. doi:10.1016/j.amsu.2022.104642
4. Hidalgo NJ, Pando E, Alberti P, et al. The role of high serum triglyceride levels on pancreatic necrosis development and related complications. BMC Gastroenterol. 2023;23(1):51. doi:10.1186/s12876-023-02684-9
5. Gukovsky I, Li N, Todoric J, Gukovskaya A, Karin M. Inflammation, autophagy, and obesity: common features in the pathogenesis of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144(6):1199-209.e4. doi:10.1053/j.gastro.2013.02.007
6. Ishqi HM, Ali M, Dawra R. Recent advances in the role of neutrophils and neutrophil extracellular traps in acute pancreatitis. Clin Exp Med. 2023;23(8):4107-4122. doi:10.1007/s10238-023-01180-4
7. Hu B, Yang XR, Xu Y, et al. Systemic Immune-Inflammation Index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212-6222. doi:10.1158/1078-0432.CCR-14-0442
8. Banks PA, Bollen TL, Dervenis C, et al. Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102-111. doi:10.1136/gutjnl-2012-302779
9. Bartl T, Bekos C, Postl M, et al. The Systemic Immune-Inflammation Index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer. J Gynecol Oncol. 2021;32(1):e1. doi:10.3802/jgo.2021.32.e1
10. Erdogan T. Role of Systemic Immune-Inflammation Index in asthma and NSAID-exacerbated respiratory disease. Clin Respir J. 2021;15(4):400-405. doi:10.1111/crj.13314
11. Liu X, Guan G, Cui X, Liu Y, Liu Y, Luo F. Systemic Immune-Inflammation Index (SII) can be an early indicator for predicting the severity of acute pancreatitis: a retrospective study. Int J Gen Med. 2021;14:9483-9489. doi:10.2147/IJGM.S343110
12. Zhang D, Wang T, Dong X, et al. Systemic Immune-Inflammation Index for predicting the prognosis of critically ill patients with acute pancreatitis. Int J Gen Med. 2021;14:4491-4498. doi:10.2147/IJGM.S314393
13. Biyik M, Biyik Z, Asil M, Keskin M. Systemic Inflammation Response Index and Systemic Immune Inflammation Index are associated with clinical outcomes in patients with acute pancreatitis? J Invest Surg. 2022;35(8):1613-1620. doi:10.1080/08941939.2022.2084187
14. Zhang Y, Xing Z, Zhou K, Jiang S. Predictive role of Systemic Inflammatory Response Index (SIRI) in the prognosis of stroke patients. Clin Interv Aging. 2021;16:1997-2007. doi:10.2147/CIA.S339221
15. Lee LE, Pyo JY, Ahn SS, Song JJ, Park YB, Lee SW. Systemic Inflammation Response Index predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis. Int Urol Nephrol. 2021;53(8): 1631-1638. doi:10.1007/s11255-020-02777-4
16. Wei L, Xie H, Yan P. Prognostic value of the Systemic Inflammation Response Index in human malignancy: a meta-analysis. Medicine (Baltimore). 2020;99(50):e23486. doi:10.1097/MD.0000000000023486
17. Wu W, Zhang Y, Zhang Y, Qu X, Zhang Z, Zhang R. Association between the Systemic Inflammation Response Index and severity of acute pancreatitis: a retrospective cohort study. J Inflamm Res. 2025;18:4471-4480. doi:10.2147/JIR.S512553
18. Araiza-Rodríguez JF, Bautista-Becerril B, Núñez-Venzor A, et al. Systemic Inflammation Indices as early predictors of severity in acute pancreatitis. J Clin Med. 2025;14(15):5465. doi:10.3390/jcm14155465
19. Ventriglia J, Petrello A, Huerta Alváro M, et al. Neutrophil to lymphocyte ratio as a predictor of poor prognosis in metastatic pancreatic cancer patients treated with nab-paclitaxel plus gemcitabine: a propensity score analysis. Gastroenterol Res Pract. 2018;2018:2373868. doi:10.1155/2018/2373868
20. Cao W, Yao X, Cen D, Zhi Y, Zhu N, Xu L. The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysis. BMC Gastroenterol. 2020;20(1):16. doi:10.1186/s12876-020-1167-x
21. Guven DC, Sahin TK, Erul E, Kilickap S, Gambichler T, Aksoy S. The association between the Pan-Immune-Inflammation Value and cancer prognosis: a systematic review and meta-analysis. Cancers (Basel). 2022;14(11):2675. doi:10.3390/cancers14112675
22. Zhang F, Hu W. Association between pan-immune-inflammation and in-hospital mortality in critically ill patients with acute pancreatitis: a cohort study from the MIMIC-IV database. BMC Gastroenterol. 2026;26(1):92. doi:10.1186/s12876-025-04521-7
Volume 4, Issue 3, 2026
Page : 48-52
_Footer